Latest News of AGIO
Is suicide contagious? Mental health experts warn of very real risk
By Fox News |
1 month ago
By providing your email, you accept Fox News' Terms of Use and Privacy Policy. Suicide, a leading cause of death in the U.S., can be contagious, especially among youth. Experts warn about suicide clus...
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results
By Yahoo! Finance |
1 month ago
Meridian Funds, managed by ArrowMark Partners, outperformed the Russell 2500 Growth Index in Q2 2024. The top holding, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), showed promising growth potential with...
Agios Pharmaceuticals' tebapivat gains FDA orphan drug designation
By Yahoo! Finance |
1 month ago
Agios Pharmaceuticals received FDA orphan drug designation for tebapivat to treat myelodysplastic syndromes (MDS), aiming to provide a new oral therapy for lower-risk MDS patients. The designation off...
-
What causes warts on hands? Here's what types of HPV can trigger this contagious skin condition.
By USA Today | 2 months agoNearly half of Americans under 60 are infected with HPV, increasing cancer risk. Warts on hands are caused by HPV strains, contagious via contact. Common warts are not an STD, distinct from genital wa...
-
Is Agios Pharmaceuticals, Inc. (AGIO) a Good Addition to Your Portfolio Now?
By Yahoo! Finance | 2 months agoCaligan Partners, a prominent hedge fund focusing on healthcare stocks, holds Agios Pharmaceuticals, Inc. as one of its top 10 investments. Agios' performance has been strong, with the recent sale of ...
-
Here's What Analysts Are Forecasting For Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) After Its Second-Quarter Results
By Yahoo! Finance | 3 months agoAgios Pharmaceuticals reported weaker-than-expected quarterly results, with revenue missing predictions. Analysts forecast a revenue increase in 2024, with a projected profit of US$2.03 per share. Des...
-
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Revenue Estimates By 12%
By Yahoo! Finance | 3 months agoAnalysts have revised down their revenue forecasts for Agios Pharmaceuticals, Inc. It is now predicted to reach US$36m in 2024, a 21% improvement. Despite this, analysts have not changed the price tar...
-
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
By Yahoo! Finance | 3 months agoAgios Pharmaceuticals announced results from a Phase 3 study on mitapivat for children with PK deficiency. The drug did not meet the primary endpoint, but showed positive results in reducing transfusi...
-
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Has Found A Path To Profitability
By Yahoo! Finance | 3 months agoAgios Pharmaceuticals, Inc. is a biopharmaceutical company focusing on cellular metabolism, aiming for profitability in 2024. Analysts predict a break-even by 2023, with a manageable 14% growth rate. ...
-
Swelling losses haven't held back gains for Agios Pharmaceuticals (NASDAQ:AGIO) shareholders since they're up 71% over 1 year
By Yahoo! Finance | 4 months agoPassive investing in index funds may match market returns, but selecting high-performing stocks can outperform. Agios Pharmaceuticals (NASDAQ: AGIO) shares surged 71% in the last year, driven by a 55%...